Completed OBSERVATIONAL NCT03923920

Screening for Systemic Amyloidosis Via the Ligamentum Flavum (ALF)

Sponsor: The Cleveland Clinic

Conditions Amyloid Amyloidosis Primary Amyloidosis of Light Chain Type Spinal Stenosis Transthyretin Amyloidosis

Interventions Biopsy

Updated 10 times since 2019 Last updated: Dec 21, 2021 Started: May 1, 2019 Primary completion: Oct 4, 2021 Completion: Dec 2, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Amyloid and Amyloidosis, this trial is completed. The trial is conducted by The Cleveland Clinic and has accumulated 10 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Dec 2021 — Jan 2022 [monthly]

Recruiting
Jun 2021 — Dec 2021 [monthly]

Recruiting

▶ Show 5 earlier versions

Jan 2021 — Jun 2021 [monthly]

Recruiting
Nov 2020 — Jan 2021 [monthly]

Recruiting
May 2020 — Nov 2020 [monthly]

Recruiting
Jun 2019 — May 2020 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
May 2019 — Jun 2019 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Cleveland Clinic

Data source: The Cleveland Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cleveland, United States